Search

Your search keyword '"Vasileiou, Elena"' showing total 3 results
Start Over Author "Vasileiou, Elena" Database Supplemental Index
3 results on '"Vasileiou, Elena"'

1. Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis.

Author

Lambe, Jeffrey, Fitzgerald, Kathryn C., Murphy, Olwen C., Filippatou, Angeliki G., Sotirchos, Elias S., Kalaitzidis, Grigorios, Vasileiou, Elena, Pellegrini, Nicole, Ogbuokiri, Esther, Toliver, Brandon, Luciano, Nicholas J., Davis, Simidele, Fioravante, Nicholas, Kwakyi, Ohemaa, Risher, Hunter, Crainiceanu, Ciprian M., Prince, Jerry L., Newsome, Scott D., Mowry, Ellen M., and Saidha, Shiv

Published
2021
Full Text
View/download PDF

2. Type of serum collection tube does not impact neurofilament light chain levels.

Author

Sotirchos, Elias S., Fitzgerald, Kathryn C., Smith, Matthew D., Vasileiou, Elena S., Resto, Yasmin, Lord, Hannah-Noelle, Mowry, Ellen M., and Calabresi, Peter A.

Abstract

Blood neurofilament light chain (NfL) has been reported to be a promising biomarker of neurological disease. NfL is predominantly measured in serum (sNfL), but there is a lack of reports regarding the effects of collection tubes on sNfL levels. We assessed sNfL levels using a novel immunoassay in 18 participants using 3 different types of serum collection tubes (no additive, with silica clot activator, and serum separator tubes). Variation observed in sNfL levels between samples from different collection tubes was similar to that observed in duplicate runs from the same tube. These findings support a lack of effect of type of serum collection tube on sNfL levels. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

3. Type of serum collection tube does not impact neurofilament light chain levels

Author

Sotirchos, Elias S., Fitzgerald, Kathryn C., Smith, Matthew D., Vasileiou, Elena S., Resto, Yasmin, Lord, Hannah-Noelle, Mowry, Ellen M., and Calabresi, Peter A.

Abstract

Blood neurofilament light chain (NfL) has been reported to be a promising biomarker of neurological disease. NfL is predominantly measured in serum (sNfL), but there is a lack of reports regarding the effects of collection tubes on sNfL levels. We assessed sNfL levels using a novel immunoassay in 18 participants using 3 different types of serum collection tubes (no additive, with silica clot activator, and serum separator tubes). Variation observed in sNfL levels between samples from different collection tubes was similar to that observed in duplicate runs from the same tube. These findings support a lack of effect of type of serum collection tube on sNfL levels.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results